Natural Alternatives International (NAII) Stock Price, News & Analysis

Company Overview

Natural Alternatives International, Inc. (NASDAQ: NAII) is a developer and contract manufacturer of nutritional supplements and related health products. Founded in 1980 and headquartered in Carlsbad, California, the company specializes in turnkey solutions for dietary supplement and functional food brands, combining scientific research with large-scale production capabilities.

NAII’s product portfolio spans a wide range of dosage forms, including softgels, tablets, capsules, powders, effervescent drink mixes and chewables. Its service offerings extend from formulation and analytical method development to stability testing, regulatory support and custom packaging, enabling clients to move seamlessly from concept through commercialization.

The company’s primary manufacturing facility is registered with the U.S. Food and Drug Administration and operates under current Good Manufacturing Practices (cGMP). In addition to its Carlsbad operations, NAII partners with distribution and logistics networks to serve markets across North America, Europe and the Asia-Pacific region, ensuring global supply chain reliability.

Guided by a management team with deep expertise in nutrition science, pharmaceutical manufacturing and quality assurance, Natural Alternatives International maintains a focus on innovation, safety and regulatory compliance. Through ongoing investment in research and collaboration with brand owners, the company seeks to support the development of differentiated, science-backed wellness products.

Key Stats

• Today's Range: $2.60 to $2.68
• 50-Day Range: $2.63 to $4.00
• 52-Week Range: $2.57 to $4.95
• Volume: 24,426 shs
• Average Volume: 11,822 shs
• Market Capitalization: $16.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Natural Alternatives International Stock Analysis - MarketRank™

Natural Alternatives International scored higher than 31% of companies evaluated by MarketBeat, and ranked 777th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Natural Alternatives International.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Natural Alternatives International is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Natural Alternatives International is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Natural Alternatives International has a P/B Ratio of 0.24. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.06% of the float of Natural Alternatives International has been sold short.

Short Interest Ratio / Days to Cover

Natural Alternatives International has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Natural Alternatives International has recently decreased by 59.46%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Natural Alternatives International does not currently pay a dividend.

Dividend Growth

Natural Alternatives International does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.06% of the float of Natural Alternatives International has been sold short.

Short Interest Ratio / Days to Cover

Natural Alternatives International has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Natural Alternatives International has recently decreased by 59.46%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: N/A

News Sentiment

Natural Alternatives International has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.48 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Natural Alternatives International this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Natural Alternatives International insiders have not sold or bought any company stock.

Percentage Held by Insiders

20.90% of the stock of Natural Alternatives International is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 32.40% of the stock of Natural Alternatives International is held by institutions.

NAII Stock Analysis - Frequently Asked Questions

How have NAII shares performed this year?

Natural Alternatives International's stock was trading at $4.31 at the beginning of 2025. Since then, NAII stock has decreased by 39.0% and is now trading at $2.63.

How were Natural Alternatives International's earnings last quarter?

Natural Alternatives International, Inc. (NASDAQ:NAII) issued its quarterly earnings data on Tuesday, September, 23rd. The company reported ($1.21) earnings per share for the quarter. The company had revenue of $33.87 million for the quarter. Natural Alternatives International had a negative trailing twelve-month return on equity of 9.69% and a negative net margin of 10.45%.

How do I buy shares of Natural Alternatives International?

Shares of NAII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Natural Alternatives International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Natural Alternatives International investors own include Ascent Solar Technologies (ASTI), Aurora Cannabis (ACB), NVIDIA (NVDA), Carnival (CCL), Meta Platforms (META), AbbVie (ABBV) and Baidu (BIDU).

Company Calendar

• Last Earnings: 9/23/2025
• Today: 10/19/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:NAII
• CIK: 787253
• Web: www.nai-online.com
• Phone: (760) 736-7700
• Fax: 760-744-9589
• Employees: 290
• Year Founded: 1980

Profitability

• EPS (Trailing Twelve Months): ($2.27)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$13.57 million
• Net Margins: -10.45%
• Pretax Margin: -8.27%
• Return on Equity: -9.69%
• Return on Assets: -4.73%

Debt

• Debt-to-Equity Ratio: 0.13
• Current Ratio: 2.06
• Quick Ratio: 1.19

Sales & Book Value

• Annual Sales: $129.86 million
• Price / Sales: 0.13
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $11.07 per share
• Price / Book: 0.24

Miscellaneous

• Outstanding Shares: 6,180,000
• Free Float: 4,886,000
• Market Cap: $16.25 million
• Optionable: Not Optionable
• Beta: 0.52